Human milk oligosaccharides – or HMOs for short – are special sugars that play a crucial role in the development of newborns and toddlers. HMOs are produced only by women in the late stages of pregnancy and breast-feeding mothers. Today however, HMOs can be produced using straight-forward biotechnology processes.difference between iron bisglycinate and ferrous sulfate One of the pioneers in tferrous gluconate krogerhis field, and a leading manufacturer of artificial HMOs that closely mimic nature, is the German biotech firm Jennewein Biotechnologie.